The biggest SHI fund, the AOK, proposes an end to free pricing in Germany
Currently, free pricing of products with a new chemical entity (NCE) applies in the first year. This means, at the time of
Category: News and updates
Experience with DiGA fast track process in Germany after one year
The BfArM assesses medical apps and digital health treatments (DiGA) in terms of patient benefit, positive effects on care, data protection and
How are digital health applications assessed in Germany?
On 19 Dec 2019, the DVG came into force in Germany. This meant that since 2020, clinicians can prescribe and SHI funds
The G-BA accepts treatment per video call
Introduction of DVPMG law On 9 June 2021, the law on the digital modernization of care (DVPMG) came into force. The key
The G-BA specifies QA requirements for cell and gene therapies in Germany
In the previous assessments of Kymriah, Yescarta, Tecartus, and Zolgensma, the G-BA had defined specific QA requirements for the use of these